Biliary interleukin-6 and tumor necrosis factor-α in patients undergoing endoscopic retrograde cholangiopancreatography

Digestive Diseases and Sciences

Volumn 42, Issue 6, 1997, Pages 1290-1294

  Rosen, Hugo R ^a   Winkle, Peter J ^b   Kendall, Bradley J ^b   Diehl, David L ^b  

^a Oregon Health Sciences   (United States)

^b NONE

Author keywords

Cholangiopancreatography; Interleukin 6; Tumor necrosis factor

Indexed keywords

CYTOKINE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BILE; BILE DUCT CARCINOMA; BILE DUCT OBSTRUCTION; BILIARY TRACT DISEASE; CHOLANGITIS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; PANCREAS CARCINOMA; PRIORITY JOURNAL;

BACTERIAL INFECTIONS; BILE; BILIARY TRACT DISEASES; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLANGITIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERLEUKIN-6; SENSITIVITY AND SPECIFICITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030812069     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018822628096     Document Type: Article

References (23)

1. Tilg H, Wilmer A, Vogel W, Herold M, Nolchen B, Judmaier G, Huber C: Serum levels of cytokines in chronic liver diseases. Gastroenterology 103:264-274, 1992
2. Ramsey AJ, Ruby J, Ramshaw IA: A case for cytokines as effector molecules in the resolution of virus infection. Immunol Today 14:155-158, 1993
3. Matsumoto K, Fujii H, Michalopoulos G, Fung JJ, Demetris AJ: Human biliary epithelial cells secrete and respond to cytokines and hepatocyte growth factors in vitro. Hepatology 20:376-382, 1994
4. Byl B, Roucloux I, Crusiaux A, Dupont E, Deviere J: Tumor necrosis factor alpha and interleukin-6 plasma levels in infected cirrhotic patients. Gastroenterology 104:1492-1497, 1993
5. Roelofsen H, VanDerVeere CN, Ottenhoff R, et al: Decreased bilirubin transport in the perfused liver of endotoxemic rats. Gastroenterology 107:1075-1084, 1994
6. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, et al: Shock and tissue injury induced by recombinant human cachexin. Science 234:470-474, 1986
7. Chrousos GP: Cytokine therapy in septic shock. N Engl J Med 333:942-943, 1995
8. Schindler R, Mancilla J, Endres S, et al: Correlations and interactions in the production of IL-6, II-1, and TNF in human blood mononuclear cells: IL-6 suppress IL-1 and TNF. Blood 75:40-47, 1990
9. Hill DB, Marsano L, Cohen D, Allen J, Shedlovsky S, McClain CJ: Increased plasma interleukin-6 concentrations in alcoholic hepatitis. J Lab Clin Med 119:547-552, 1992
10. McClain C, Hill D, Schmidt J, Diehl AM: Cytokines and alcoholic liver disease. Semin Liver Dis 13:170-182, 1993
11. Cominelli F, Nast CC, Duchini A, Lee M: Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis. Gastroenterology 103:65-71, 1992
12. Gionchetti P, Vaira D, Campieri M, Holton J, Menegatti M, Belluzi A, et al: Enhanced mucosal interleukin-6 and -8 in Helicobater pyloria-positive dyspeptic patients. Am J Gastroenterol 89:883-887, 1994
13. Kusske AM, Rongione AJ, Reber HA: Cytokines and acute pancreatitis. Gastroenterology 110:639-642, 1996
14. Bemelmans MH, Greve JW, Gouma DJ, Buurman WA: Increased concentrations of tumor necrosis factor and soluble TNF receptors in biliary obstruction in mice; soluble TNF receptors as prognostic factors for mortality. Gut 38:447-453, 1996
15. Whiting JF, Green RM, Rosenbluth AB, Gollan JL: Tumor necrosis factor-alpha decreases hepatocyte bile salt uptake and mediates endotoxin-induced cholestasis. Hepatology 22:1273-1278, 1995
16. Rosen HR, Lebow LT, LePage E, Demetriou AA: Plasma cytokine levels in patients with fulminant hepatic failure treated with a bioartiflcial liver. Gastroenterology 106(4):A971, 1994
17. Andus T, Gross V, Holstege A, et al: High concentrations of soluble tumor necrosis factor receptors in ascites. Hepatology 16:749-755, 1992
18. Engleberts I, Stephens S, Francot GJM, Van der Linden CJ, Buurman WA: Evidence of different effects of soluble TNF-receptors on various TNF measurements in human biological fluids. Lancet 338:515-516, 1991
19. Whiting JF, Green RM, Rosenbluth AB, Gollan JL: Tumor necrosis factor-alpha decrease hepatocyte bile salt uptake and mediates endotoxin-induced cholestasis. Hepatology 22:1273-1278, 1995
20. Moseley RH: Sepsis-associated cholestasis. Gastroenterology 112:302-306, 1997
21. Fong Y, Moldawer LL, Shires GT, Lowry SF: The biologic characteristics of cytokines and their implication in surgical injury. Surg Gynecol Obstet 170:363-378, 1990
22. Houssiau FA, Devogelaer JP, Van Damme J, De Deuxchaisnes CN, Van Snick J: Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 31:784-788, 1988
23. Wollvekamp MCJ, Marquet RL: Interleukin-6: Historical background, genetics and biological significance. Immunol Lett 24:1-10, 1990